Correlation Between Evoke Pharma and Dynavax Technologies

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Evoke Pharma and Dynavax Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Evoke Pharma and Dynavax Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Evoke Pharma and Dynavax Technologies, you can compare the effects of market volatilities on Evoke Pharma and Dynavax Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Evoke Pharma with a short position of Dynavax Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Evoke Pharma and Dynavax Technologies.

Diversification Opportunities for Evoke Pharma and Dynavax Technologies

-0.36
  Correlation Coefficient

Very good diversification

The 3 months correlation between Evoke and Dynavax is -0.36. Overlapping area represents the amount of risk that can be diversified away by holding Evoke Pharma and Dynavax Technologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dynavax Technologies and Evoke Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Evoke Pharma are associated (or correlated) with Dynavax Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dynavax Technologies has no effect on the direction of Evoke Pharma i.e., Evoke Pharma and Dynavax Technologies go up and down completely randomly.

Pair Corralation between Evoke Pharma and Dynavax Technologies

Given the investment horizon of 90 days Evoke Pharma is expected to under-perform the Dynavax Technologies. In addition to that, Evoke Pharma is 1.79 times more volatile than Dynavax Technologies. It trades about -0.18 of its total potential returns per unit of risk. Dynavax Technologies is currently generating about -0.05 per unit of volatility. If you would invest  1,350  in Dynavax Technologies on September 13, 2024 and sell it today you would lose (42.00) from holding Dynavax Technologies or give up 3.11% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Evoke Pharma  vs.  Dynavax Technologies

 Performance 
       Timeline  
Evoke Pharma 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Evoke Pharma are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite quite inconsistent basic indicators, Evoke Pharma may actually be approaching a critical reversion point that can send shares even higher in January 2025.
Dynavax Technologies 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Dynavax Technologies are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain basic indicators, Dynavax Technologies showed solid returns over the last few months and may actually be approaching a breakup point.

Evoke Pharma and Dynavax Technologies Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Evoke Pharma and Dynavax Technologies

The main advantage of trading using opposite Evoke Pharma and Dynavax Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Evoke Pharma position performs unexpectedly, Dynavax Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dynavax Technologies will offset losses from the drop in Dynavax Technologies' long position.
The idea behind Evoke Pharma and Dynavax Technologies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Other Complementary Tools

Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance